Norges Bank’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
DTC
FCM
BBA
TCM
Norges Bank's IMVT Position: Q2 2026 in Review
Norges Bank opened a new position in Immunovant (IMVT) in Q2 2026: 19,302 shares worth $744K. The stake represents ﹤0.01% of the portfolio and ranks #1594 among its holdings. This is a return to the name: Norges Bank previously reported a position in IMVT as recently as Q2 2025.
Norges Bank first reported a position in IMVT in Q4 2020 and has held it in 17 quarters since. The position peaked at $21.2M in Q1 2024. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.
- Norges Bank held 19,302 shares of Immunovant worth $744K as of Q2 2026.
- Immunovant was a new Norges Bank position in Q2 2026.
- Immunovant made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1594 holding.
- Norges Bank first reported a position in Immunovant in Q4 2020 and has held it in 17 quarters since.
- Norges Bank's Immunovant position peaked at $21.2M in Q1 2024.
- 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.